The influence of citrate concentrations on PFA-100 closure times, platelet hyper-reactivity and aspirin monitoring

Thrombosis Research

Volumn 126, Issue 2, 2010, Pages

  Harrison, Paul ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ARACHIDONIC ACID; CITRIC ACID; COLLAGEN; CYCLOOXYGENASE 1; WARFARIN;

ANALYZER; BLOOD SAMPLING; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; HEMATOCRIT; HUMAN; LETTER; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE; THROMBOGENESIS; THROMBUS;

ASPIRIN; BLOOD PLATELETS; CITRIC ACID; DRUG MONITORING; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS;

EID: 77955672341     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.11.001     Document Type: Letter

References (20)

1. Nazarian SM, Thompson JB, Gluckman TJ, Laws K, Jani JT, Kickler TS, et al. Clinical and laboratory factors associated with shear-dependent platelet hyper-reactivity in patients on chronic aspirin therapy. Thromb Res 2009. Electronic publication online.
2. C.P. Hayward, P. Harrison, M. Cattaneo, T.L. Ortel, and A.K. Rao Platelet function analyser (PFA-100) closure time in the evaluation of platelet disorders and platelet function J Thromb Haemostasis 4 2006 1 8
3. E.J. Heilmann, S.K. Kundu, R. Sio, C. Garcia, R. Gomez, and D.J. Christie Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100 system Thromb Res 87 1997 159 164
4. P. Harrison, I. Mackie, A. Mathur, M.S. Robinson, Y. Hong, and J.D. Erusalimsky Platelet hyper-function in acute coronary syndromes Blood Coagul Fibrinolysis 16 2005 557 562
5. T. Chakroun, G. Gerotziafas, F. Robert, C. Lecrubier, M.M. Samama, and M. Hatmi In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor Br J Haematol 124 2004 80 85
6. D.J. McCabe, P. Harrison, I.J. Mackie, P.S. Sidhu, A.S. Lawrie, and G. Purdy Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA Platelets 16 2005 269 280
7. M. Cattaneo Laboratory detection of 'aspirin resistance': what test should we use (if any)? Eur Heart J 28 2007 1673 1675
8. P. Harrison, H. Segal, K. Blasbery, C. Furtado, L. Silver, and P.M. Rothwell Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry Stroke 36 2005 1001 1005
9. P. Harrison, H. Segal, L. Silver, A. Syed, F.C. Cuthbertson, and P.M. Rothwell Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests Platelets 19 2008 119 124
10. M. Crescente, C.A. Di, L. Iacoviello, J. Vermylen, C. Cerletti, and G.G. De Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review Thromb Haemost 99 2008 14 26
11. G. Krasopoulos, S.J. Brister, W.S. Beattie, and M.R. Buchanan Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis BMJ 336 2008 195 198
12. M. Frossard, I. Fuchs, J.M. Leitner, K. Hsieh, M. Vlcek, and H. Losert Platelet function predicts myocardial damage in patients with acute myocardial infarction Circulation 110 2004 1392 1397
13. I. Fuchs, M. Frossard, A. Spiel, E. Riedmuller, A.N. Laggner, and B. Jilma Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS J Thromb Haemost 4 2006 2547 2552
14. P. Harrison, and D. Keeling Platelet hyperactivity and risk of recurrent thrombosis J Thromb Haemost 4 2006 2544 2546
15. H. Haubelt, C. Anders, A. Vogt, P. Hoerdt, U.T. Seyfert, and P. Hellstern Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals Br J Haematol 130 2005 759 767
16. I.C. Nitu-Whalley, C.A. Lee, S.A. Brown, A. Riddell, and C. Hermans The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood group Haemophilia 9 2003 298 302
17. A. Antovic, C. Perneby, G.J. Ekman, H.N. Wallen, P. Hjemdahl, M. Blomback, and S. He Marked Increase of fibrin gel permeability with very low ASA treatment Thromb Res 116 2005 509 517
18. D.J. Christie, T. Avari, L.R. Carrington, E. Cohen, B. DeBiase, and P. Harrison Platelet Function Testing by Aggregometry: Approved Guideline 28 2008 Clinical and Laboratory Standards Institute Wayne PA 1 45
19. B. Jilma Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction J Lab Clin Med 138 2001 152 163
20. D.J. Christie, K. Kottke-Marchant, and R.T. Gorman Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy Platelets 2007 1 7